News

Drug Delivery Business4d
Modular Medical study shows potential benefits of pump-delivered GLP-1s
(Nasdaq:MODD) has shared new data highlighting the use of its insulin pump technology to deliver GLP-1 therapeutics.
Healio4d
Two intermittent fasting strategies equally effective for weight loss, glycemic control
A strategy of time-restricted eating with energy restriction and intermittent energy restriction alone both conferred ...
Healthline1d
10 Exercises for Diabetes: Walking, Yoga, Swimming, and More - Healthline
If you have type 2 diabetes, exercise is an important habit that can help you manage your blood sugar levels. Find out the best exercises for type 2 diabetes.
manilatimes5d
Fractyl Health Presents New Data at the American Diabetes Association's 85th Scientific Sessions Demonstrating its Rejuva® Smart GLP-1™ Pancreatic Gene Therapy Platform ...
BURLINGTON, Mass., June 23, 2025 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the Company), a metabolic therapeutics company focused on pattern-breaking approaches to treat the root causes ...
pharmaphorum1d
Lilly to invest $2.5bn for obesity, diabetes drug production
Eli Lilly has followed Novo Nordisk in announcing a big investment in its manufacturing network, intended to meet anticipated strong future demand for diabetes and obesity drugs. The pharma group ...
pharmaphorum2d
Vertex buys diabetes cell therapy rival ViaCyte for $320m
Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880.
Drug Delivery Business5d
Study backs Biolinq intradermal sensor in muscle loss prevention during GLP-1 therapy
The system — similar to continuous glucose monitoring (CGM) uses a new method of continuously sensing specific chemistry ...